<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03535337</url>
  </required_header>
  <id_info>
    <org_study_id>ATN 144</org_study_id>
    <nct_id>NCT03535337</nct_id>
  </id_info>
  <brief_title>Adherence Interventions for HIV Youth Via Text &amp; Cell Phone - Sequential Multiple Assignment Randomized Trial (SMART)</brief_title>
  <acronym>SMART</acronym>
  <official_title>Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Messaging and Cell Phone Support Embedded Within the Sequential Multiple Assignment Randomized Trial (SMART) Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florida State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunter College of City University of New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Florida State University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test an adaptive adherence intervention, which utilizes two&#xD;
      mobile health (mHealth) intervention designs, in an effort to promote adherence to&#xD;
      antiretroviral therapy (ART) and achieve and maintain viral load (VL) suppression in youth&#xD;
      living with HIV (YLH) while increasing understanding of the context for wide-scale&#xD;
      implementation of cell phone support (CPS) and text messaging support (SMS), with and without&#xD;
      incentives.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consist of two points of randomization. The first step involves randomization&#xD;
      of participants to receive either CPS or SMS using a 1:1 allocation ratio. Both intervention&#xD;
      conditions will receive 3 months of intervention (i.e., 12 weeks of CPS or SMS).&#xD;
&#xD;
      The second step involves a stratified randomization in blocks with 8 possible intervention&#xD;
      trajectories. Within each condition, participants are categorized into two groups -&#xD;
      responders with VL&lt;200 (Rsp) and non-responders with VL ≥200 (NRsp). Responders in the CPS&#xD;
      condition will be randomly assigned to receive either 3 months of CPS tapered (CPS-T)&#xD;
      intervention followed by standard care (SC) or only SC. Similarly, responders in the&#xD;
      SMScondition will be randomly assigned to receive either 3 months of SMS tapered (SMS-T)&#xD;
      intervention followed by SC or only SC. Non-responders in both CPS and SMS conditions will be&#xD;
      randomly assigned to receive either 3 months of incentivized CPS (CPS-I) followed by 3 months&#xD;
      of CPS-T and 3 months of SC or 3 months of incentivized SMS (SMS-I) followed by 3 months of&#xD;
      SMS-T and 3 months of SC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Multiple Assignment Randomized Trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Viral Load Comparison</measure>
    <time_frame>3 months</time_frame>
    <description>Viral Load (VL) suppression rate will be compared between the CPS and SMS groups using an X2 test. Also the drop in VL will be compared between the two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence Rate</measure>
    <time_frame>3 months</time_frame>
    <description>Medication adherence rates will be compared between CPS and SMS groups, focusing on non-responders.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>CPS-Rsp-T</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of CPS Rsp will receive 3 months of CPS-T intervention followed by SC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPS-Rsp-SC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of CPS Rsp's intervention will discontinue and they'll receive SC only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPS-NRsp-I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of CPS NRsp will receive 3 months of CPS-I followed by 3 months of CPS-T and 3 months of SC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPS-NRsp-SMS-I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of CPS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS-Rsp-T</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of SMS Rsp will receive 3 months of SMS tapered (SMS-T) intervention followed by SC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS-Rsp-SC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of SMS Rsp, intervention will discontinue and they'll receive SC only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS-NRsp-CPS-I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of SMS NRsp will receive 3 months of CPS-I followed by 3 months CPS-T and 3 months SC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS-NRsp-I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 3 months of intervention, this group of SMS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CPS</intervention_name>
    <description>Assessment of participant's medication adherence and barrier problem solving via phone conversation</description>
    <arm_group_label>CPS-NRsp-I</arm_group_label>
    <arm_group_label>CPS-NRsp-SMS-I</arm_group_label>
    <arm_group_label>CPS-Rsp-SC</arm_group_label>
    <arm_group_label>CPS-Rsp-T</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS</intervention_name>
    <description>Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.</description>
    <arm_group_label>SMS-NRsp-CPS-I</arm_group_label>
    <arm_group_label>SMS-NRsp-I</arm_group_label>
    <arm_group_label>SMS-Rsp-SC</arm_group_label>
    <arm_group_label>SMS-Rsp-T</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  HIV diagnosis&#xD;
&#xD;
          -  Viral load ≥ 200 copies/mL within 3 months prior to enrollment or self-reported&#xD;
             adherence ≤ 80%&#xD;
&#xD;
          -  ART medication regimen prescribed minimum of 3 months prior to eligibility VL or&#xD;
             self-reported adherence&#xD;
&#xD;
          -  Sole owner of device capable of sending/receiving calls and text messages&#xD;
&#xD;
          -  Willingness to permit research team to communicate with their HIV care provider team&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mental, physical, or emotional capacity prevents completion of protocol as written&#xD;
&#xD;
          -  Inability to understand written/spoken English&#xD;
&#xD;
          -  Concurrent participant in any adherence behavioral research intervention&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sylvie Naar, PhD</last_name>
    <phone>248-207-2903</phone>
    <email>sylvie.naar@med.fsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The City University of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen MacDonell, PhD</last_name>
      <phone>212-206-7919</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Florida State University</investigator_affiliation>
    <investigator_full_name>Sylvie Naar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Interventions</keyword>
  <keyword>youth living with HIV</keyword>
  <keyword>mHealth</keyword>
  <keyword>ART adherence</keyword>
  <keyword>adaptive intervention</keyword>
  <keyword>cell phone</keyword>
  <keyword>text messaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

